Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi awarded 2025 Nobel Prize in Physiology or Medicine for discoveries in peripheral immune tolerance.
ByAinvest
Monday, Oct 6, 2025 5:39 am ET1min read
Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi awarded 2025 Nobel Prize in Physiology or Medicine for discoveries in peripheral immune tolerance.
Three distinguished scientists—Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi—have been awarded the 2025 Nobel Prize in Physiology or Medicine. The Nobel Assembly at Karolinska Institutet in Stockholm announced the award on October 6, 2025, recognizing their groundbreaking discoveries concerning peripheral immune tolerance .The annual Nobel Prizes, established in the will of Alfred Nobel, cover achievements in physics, chemistry, medicine, literature, and peace. A prize in economic sciences was added in 1968 by Sweden’s central bank. This year's medicine Nobel highlights the importance of immune tolerance in maintaining health and preventing diseases.
The laureates' work focuses on understanding how the immune system can recognize and tolerate foreign substances, a crucial mechanism for preventing autoimmune disorders and ensuring proper functioning of transplanted organs. Their discoveries have significant implications for the development of new therapies and treatments, particularly in the fields of immunology and transplantation.
This year's award follows a trend of recognizing pivotal advancements in medicine. Notable past winners include those who discovered insulin in 1923, penicillin in 1945, and the molecular structure of DNA in 1962. The Nobel Prizes continue to celebrate and honor the most outstanding contributions to science and humanity.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet